Bristol-Myers Squibb Co. has announced some executive moves within its senior management team. The company said Wednesday that Giovanni Caforio has been promoted to president of U.S. Pharmaceuticals. He previously was senior vice president of oncology and immunology global commercialization.
Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.
Prasco Laboratories has been named the exclusive U.S. distributor and pharmaceutical services provider for Aspen Global branded prescription drugs. Prasco said Tuesday that Aspen Global, a subsidiary of South Africa-based Aspen Pharmacare Holdings Ltd., is Africa’s largest pharmaceutical company.
The ophthalmic and otic products of Falcon Pharmaceuticals Ltd., the U.S. generics business of Alcon Inc., are being brought under the Sandoz umbrella. Sandoz, the generic pharmaceuticals arm of Novartis, said Tuesday that the Falcon products are slated to become part of its U.S.
Par Pharmaceutical Cos. has acquired rights to three products from Teva Pharmaceuticals in connection with Teva’s acquisition of Cephalon.
Archimedes Pharma Ltd. and its subsidiary, Archimedes Pharma U.S. Inc., have rolled out Lazanda fentanyl nasal spray to U.S. pharmacies.
Kirby Lester has introduced the Kirby Lester 60/30 Combination, a solution that the company bills as packing "a one-two pharmacy automation punch.
Lannett Co. has launched a trio of new generic drug products recently approved by the Food and Drug Administration. The new generic medications include two appetite suppressants — diethylpropion tablets (25 mg) and phentermine HCI capsules (37.
Teva Pharmaceutical Industries Ltd. has closed its acquisition of Cephalon Inc. Teva said that as of Friday, Cephalon became a wholly owned subsidiary of and ceased to be traded on Nasdaq. The two pharmaceutical companies unveiled the $6.8 billion deal this past spring.
Eli Lilly and Co. is promoting a trio of senior executives with the announcement that longtime company Bryce Carmine and Frank Deane plan to retire. The pharmaceutical company said this week that Carmine and Deane are slated to retire as of Dec. 31.
Energizer Holdings Inc. has expanded its lineup of products aimed at keeping consumers’ portable devices powered up and has added a home lighting line to its portfolio.
Next spring, Beiersdorf AG will have a new chief executive officer at the helm. The supervisory board of the skin care and cosmetics manufacturer has named Stefan Heidenreich as the company’s next chief executive officer. Plans call for Heidenreich to take the reins as CEO on April 26, 2012.
Johnson & Johnson has made changes to its customer development organization in an effort to simplify it, streamline processes, speed execution and enable faster decision-making.
Jamie Egasti, former chief executive officer of The Folgers Coffee Co. and president of Procter & Gamble Co.’s global snacks and coffee unit, has joined Catalina Marketing Corp. as CEO.
Richard Clark, chairman and former chief executive officer of Merck, plans to retire from the company and its board later this year. The pharmaceutical giant said Thursday that Clark, who has been with Merck nearly four decades, is slated to retire effective Dec. 1.
Hershey Co. and the Ferrero Group in North America have entered a joint warehousing, transportation and distribution arrangement.
